GlassScriptPhysician profile
Monique P Hamilton
NPI 1346219375
$2,506.86
in general payments reported to CMS, 2019-2025
29 companies · $406 in 2025
The $406 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $258 · 2021: $360 · 2022: $529 · 2023: $362 · 2024: $308 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $380.45 | 2019-2023 | |
| Astellas Pharma US INC | $255.36 | 2023-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $237.13 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mylan Pharmaceuticals INC. | $139.77 | 2019-2022 | |
| Boston Scientific Corporation | $139.08 | 2023-2024 | Advantage System |
| Myovant Sciences INC. | $135.78 | 2021-2022 | |
| Organon LLC | $132.78 | 2021-2025 | Nexplanon |
| Pfizer INC. | $124.48 | 2019-2023 | |
| Scynexis, INC. | $114.02 | 2022 | |
| Exeltis, USA INC. | $108.54 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $106.26 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.90 | 2019-2025 | |
| Millicent US INC | $87.73 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $54.79 | 2023-2025 | Myfembree |
| Lupin INC. | $51.94 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $48.72 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $47.33 | 2019-2021 | |
| Amgen INC. | $33.87 | 2022-2023 | Evenity, Prolia |
| Lsi Solutions INC | $28.36 | 2021 | |
| Meditrina | $26.51 | 2025 | |
| Duchesnay USA Incorporated | $24.59 | 2019 | |
| Daiichi Sankyo INC. | $21.74 | 2022 | |
| Hologic Sales and Service, LLC | $20.70 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.57 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $15.57 | 2025 | Zurzuvae |
| Asensus Surgical, INC. | $14.97 | 2023 | Senhance |
| Avion Pharmaceuticals | $13.21 | 2019 | |
| Therapeuticsmd, INC. | $13.20 | 2022 | |
| Coopersurgical, INC. | $11.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.